Journals / Akdeniz Tıp Dergisi / 2021 / Cilt: 7 - Sayı: 3

Invasıve Breast Cancer Histopathological Properties and Hormone Receptors In Young Women

Genç Kadınlarda İnvaziv Meme Kanseri Histopatolojik Özellikleri ve Hormon Reseptörleri

Pages
372–376
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, it shows that cancers seen in this age group will progress more biologically and the prognosis will be poor.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective:Breast cancer is common, especially in older women.
📊
Key Findings & Data:The aim of our study is to evaluate the clinical, histopathological features, and hormone receptors of breast cancer in women under the age of 40, and to create datasets to develop different methods in medical treatments to be applied to patients of this age.
💡
Conclusion & Impact:Therefore, it shows that cancers seen in this age group will progress more biologically and the prognosis will be poor.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Meme Kanseri · Genç Kadın · Histopatolojik Özellikleri

Abstract

Objective:Breast cancer is common, especially in older women. It is also one of the leading causes of cancer-related deaths in young women. Survey in young women is shorter and the response to medical treatment is lower, because cancer cases in this group of patients are considered as differences in hormone receptors in cancer cells, unlike those seen in other age groups. The aim of our study is to evaluate the clinical, histopathological features, and hormone receptors of breast cancer in women under the age of 40, and to create datasets to develop different methods in medical treatments to be applied to patients of this age. Methods:Localization, tumor size, histological grade, lymph node involvement, multifocality/multicentricity, distant organ metastasis, hormone receptor (Estrogen-ER, progesterone-PR) status, HER2 and ki-67 proliferation markers were retrospectively analyzed in 72 invasive breast carcinoma cases under the age of 40 diagnosed in the pathology clinic of our hospital. Results:The average age of the patients is 35.31 and 59.7 % of them are localized in the right breast. Ductal carcinoma is the most common histological type, and high grade was detected in 52.8 % of cases. The majority of cases were ER (87.5%) and PR (73.6 %) positive, HER2 (83.3 %) negative. Ki-67 proliferation index was observed at a high rate in 52.8 %. Conclusion:These findings show that breast cancer tumors observed in young women have higher histological grade and high proliferation index. Therefore, it shows that cancers seen in this age group will progress more biologically and the prognosis will be poor.

Özet

Giriş/Amaç:Meme kanseri, özellikle ileri yaş kadınlarda yaygındır. Genç kadınlarda da kansere bağlı ölümlerin önde gelen nedenleri arasındadır. Genç kadınlarda survey daha kısa olup, medikal tedaviye cevap daha düşük olmaktadır, nedeni bu hasta grubunda görülen kanser olgularının diğer yaş gruplarında görülenlerden farklı olarak kanser hücrelerindeki hormon reseptörlerindeki farklılıklar olarak düşünülmektedir. Çalışmamızdaki amaç 40 yaş altı kadınlardaki meme kanserinin klinik, histopatolojik özellikleri, ve hormon reseptörleri değerlendirip, bu yaştaki hastalara uygulanacak medikal tedavilerde farklı yöntemler geliştirilmesi için veri setleri oluşturmaktır. Gereç ve Yöntemler:Hastanemiz patoloji kliniğinde tanı almış 40 yaş altı 72 invaziv meme karsinom vakası; lokalizasyon, tümör büyüklüğü, histolojik grade, lenf nodu tutulumu, multifokalite/multisentrisite, uzak organ metastazı, hormon reseptör (Östrojen-ER, progesteron-PR) durumu, HER2 ve ki-67 proliferasyon belirteçleri retrospektif olarak incelendi. Bulgular:Hastaların yaş ortalaması 35.31 olup, %59.7?si sağ memede lokalizedir. Duktal karsinoma en yaygın histolojik tip olup, olguların %52.8?inde yüksek grade saptandı. Vakaların büyük çoğunluğu ER (%87.5) ve PR (%73.6) pozitif, HER2 (%83.3) negatif bulundu. Ki-67 proliferasyon indeksi %52.8?inde yüksek oranda izlendi. Sonuç:Bu bulgularla genç kadınlarda izlenen meme kanseri tümörlerinin daha yüksek histolojik grade ve yüksek proliferasyon indeksine sahip olduğunu göstermektedir. Bu nedenle bu yaş grubunda görülen kanserlerin biyolojik olarak daha agresif seyredeceğini ve prognozun kötü olacağını göstermektedir.

🔖

Cite This Article

CELEPLİ, S., CELEPLİ, P., HÜCÜMENOĞLU, S., BİGAT, İ. (2022). Invasıve Breast Cancer Histopathological Properties and Hormone Receptors In Young Women. Akdeniz Tıp Dergisi, Cilt: 7 - Sayı: 3, 372–376. https://ajindex.com/articles/434234

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Mehrabi E, Hajian S, Simbar M, Hoshyari M, Zayeri F. Coping response following a diagnosis of breast cancer: A systematic review. Electronic physician 2015; 7(8): 1575
  2. Assi HA, Khoury KE, Dbouk H, Khalil LE, Mouhieddine TH, El Saghir NS. Epidemiology and prognosis of breast cancer in young women. J ThoracDis 2013; 5(1): S2-8
  3. Reyna C, Lee MC. Breastcancer in young women: special considerations in multidisciplinary care. Journal of multidisciplinary healthcare 2014; 7: 419-29
  4. Chung M, Chang HR, Bland KI, Wanebo HJ. Younger women with breast carcinoma have poorer prognosth an older women. Cancer 1996; 77: 97-103
  5. Gajdos C, Tarrter PI, Bleiweiss IJ, Bodian C, Brower ST. Stage 0 tostage III breast cancer in young women. J AmColl Surg 2000; 190: 523-9
  6. Azim HA, Partridge AH. Biology of breast cancer in young women. Breast Cancer Res 2014; 16: 427
  7. Fredholm H, Eaker S, Frisell J, Holmberg L, Fredriksson I, Lindman H. Breast cancer in young women: poor survival despite intensive treatment. PLoSOne 2009; 4:e7695
  8. Cancello G, Maisonneuve P, Rotmensz N, Viale G, Mastropasqua MG, Pruneri G, Veronesi P, Torrisi R, Montagna E, Luini A, Intra M, Gentilini O, Ghisini R, Goldhirsch A, Colleoni M. Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women ( 9- Han W, Kang SY. Relationship between age at diagnosis and outcome of premenopausal breast cancer: ageless than 35 years is a reason ablecut-off for defining young age-onset breast cancer. Breast Cancer Res Treat 2010; 119:193–200
  9. Azim HA Jr, Michiels S, Bedard PL, Singhal SK, Criscitiello C, Ignatiadis M, Haibe-Kains B, Piccart MJ, Sotiriou C, Loi S. Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling. Clin Cancer Res 2012; 18:1341–1351
  10. Maughan KL, Lutterbie MA, Ham PS. Treatment of breast cancer. Am Fam Physician 2010; 81(11): 1339-46
  11. Januškevičienė I, PetrikaitėV. Heterogeneity of breast cancer: the importance of interaction between different tumor cell populations. Life Sci 2019 Oct 24;239:117009
  12. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991; 19: 403–10 14- Goldhirsch A, Winer EP, Coates AS, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Pr